OrbiMed Advisors

OrbiMed AdvisorsOrbiMed Advisors
OrbiMed Advisors

OrbiMed Advisors

OrbiMed is a global investment firm focused exclusively on the healthcare sector, from seed-stage to multinational corporations.

1989VC50 portfolio$20.6B AUMNew York, United States

About

OrbiMed invests globally across the healthcare industry, employing a multi-strategy approach that encompasses public equity, private equity, and private credit/royalty structures. The firm aims to drive innovation, address unmet medical needs, and improve patient outcomes by supporting companies throughout their lifecycle. They focus on biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Frequently asked

What type of investor is OrbiMed Advisors?

OrbiMed invests globally across the healthcare industry, employing a multi-strategy approach that encompasses public equity, private equity, and private credit/royalty structures. The firm aims to drive innovation, address unmet medical needs, and improve patient outcomes by supporting companies throughout their lifecycle. They focus on biopharmaceuticals, medical devices, digital health, diagnost…

What kind of firm is OrbiMed Advisors?

OrbiMed Advisors is a VC.

What is OrbiMed Advisors's assets under management?

OrbiMed Advisors manages approximately $20.6B in assets.

Where is OrbiMed Advisors based?

OrbiMed Advisors is based in New York, United States.

What sectors does OrbiMed Advisors focus on?

OrbiMed Advisors focuses on Biopharmaceuticals, Medical Devices, Digital Health, Diagnostics.

AUM
$20.6B
PORTFOLIO
50
Scores
Measured, not editorial
Domain Rating
49/100

Strength of the site’s backlink profile, on the industry-standard 0-100 scale. Licensed third-party data, not our opinion.

Check any domain free

Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.

Comments

No comments yet. Be the first to share your take.

Founders (1)